Close

Baird Upgrades Ultragenyx Pharma (RARE) to Outperform

November 3, 2022 6:50 AM EDT Send to a Friend
Baird analyst Joel Beatty upgraded Ultragenyx Pharma (NASDAQ: RARE) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login